We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Arbaclofen in Children and Adolescents With ASD (AIMS2-CT1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03682978
Recruitment Status : Recruiting
First Posted : September 25, 2018
Last Update Posted : August 11, 2022
UMC Utrecht
Information provided by (Responsible Party):
Celso Arango, MD, PhD